CoChat

The Intestinal Microbiota: Impacts of Antibiotics Therapy, Colonization Resistance, and Diseases

Shah, Taif, Baloch, Zulqarnain, Shah, Zahir, Cui, Xiuming, Xia, Xueshan · 2021 · International Journal of Molecular Sciences
Cited by 106

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Trillions of microbes exist in the human body, particularly the gastrointestinal tract, coevolved with the host in a mutually beneficial relationship. The main role of the intestinal microbiome is the fermentation of non-digestible substrates and increased growth of beneficial microbes that produce key antimicrobial metabolites such as short-chain fatty acids, etc., to inhibit the growth of pathogenic microbes besides other functions. Intestinal microbiota can prevent pathogen colonization through the mechanism of colonization resistance. A wide range of resistomes are present in both beneficial and pathogenic microbes. Giving antibiotic exposure to the intestinal microbiome (both beneficial and hostile) can trigger a resistome response, affecting colonization resistance. The following review provides a mechanistic overview of the intestinal microbiome and the impacts of antibiotic therapy on pathogen colonization and diseases. Further, we also discuss the epidemiology of immunocompromised patients who are at high risk for nosocomial infections, colonization and decolonization of multi-drug resistant organisms in the intestine, and the direct and indirect mechanisms that govern colonization resistance to the pathogens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22126597

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 133

  1. Ursell, 2012, Defining the human microbiome, Nutr. Rev., 70, S38, 10.1111/j.1753-4887.2012.00493.x · DOI · Paper page
  2. Baghbani, 2020, Dual and mutual interaction between microbiota and viral infections: A possible treat for COVID-19, Microb. Cell Fact., 19, 217, 10.1186/s12934-020-01483-1 · DOI
  3. Fernandes, 2019, Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy, Biochim. Biophys. Acta Mol. Basis Dis., 1865, 1876, 10.1016/j.bbadis.2018.09.032 · DOI · Paper page
  4. Kumar Singh, A., Cabral, C., Kumar, R., Ganguly, R., Kumar Rana, H., Gupta, A., Rosaria Lauro, M., Carbone, C., Reis, F., and Pandey, A.K. (2019). Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency. Nutrients, 11. · DOI · Paper page
  5. McFarland, 2008, Antibiotic-associated diarrhea: Epidemiology, trends and treatment, Future Microbiol., 3, 563, 10.2217/17460913.3.5.563 · DOI · Paper page
  6. Beaugerie, 2003, Antibiotic-associated diarrhoea and Clostridium difficile in the community, Aliment. Pharmacol. Ther., 17, 905, 10.1046/j.1365-2036.2003.01531.x · DOI
  7. Ramirez, 2020, Antibiotics as Major Disruptors of Gut Microbiota, Front. Cell. Infect. Microbiol., 10, 572912, 10.3389/fcimb.2020.572912 · DOI · Paper page
  8. Szajewska, 2016, Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children, J. Pediatr. Gastroenterol. Nutr., 62, 495, 10.1097/MPG.0000000000001081 · DOI · Paper page
  9. Alonso, 2013, Clostridium difficile infection among hematopoietic stem cell transplant recipients: Beyond colitis, Curr. Opin. Infect. Dis., 26, 326, 10.1097/QCO.0b013e3283630c4c · DOI
  10. Alyousef, 2018, Clostridium difficile: Epidemiology, Pathogenicity, and an Update on the Limitations of and Challenges in Its Diagnosis, J. AOAC Int., 101, 1119, 10.5740/jaoacint.17-0352 · DOI
  11. Ofori, 2018, Community-acquired Clostridium difficile: Epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies, J. Hosp. Infect., 99, 436, 10.1016/j.jhin.2018.01.015 · DOI
  12. Leffler, 2015, Clostridium difficile infection, N. Engl. J. Med., 372, 1539, 10.1056/NEJMra1403772 · DOI · Paper page
  13. Malfertheiner, 2017, Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report, Gut, 66, 6, 10.1136/gutjnl-2016-312288 · DOI · Paper page
  14. Li, 2017, Alterations in Gastric Microbiota after H. Pylori Eradication and in Different Histological Stages of Gastric Carcinogenesis, Sci. Rep., 7, 44935, 10.1038/srep44935 · DOI · Paper page
  15. Yap, T.W., Gan, H.M., Lee, Y.P., Leow, A.H., Azmi, A.N., Francois, F., Perez-Perez, G.I., Loke, M.F., Goh, K.L., and Vadivelu, J. (2016). Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults. PLoS ONE, 11. · DOI
  16. Szajewska, 2015, Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults, Aliment. Pharmacol. Ther., 42, 1149, 10.1111/apt.13404 · DOI · Paper page
  17. Losurdo, 2018, Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis, World J. Gastroenterol., 24, 139, 10.3748/wjg.v24.i1.139 · DOI
  18. Kronman, 2012, Antibiotic exposure and IBD development among children: A population-based cohort study, Pediatrics, 130, e794, 10.1542/peds.2011-3886 · DOI · Paper page
  19. Vergara, 2018, Intestinal microbiota and antibiotic resistance: Perspectives and solutions, Hum. Microbiome J., 9, 11, 10.1016/j.humic.2018.05.002 · DOI
  20. Baron, S.A., Diene, S.M., and Rolain, J.-M. (2018). Human microbiomes and antibiotic resistance. Hum. Microbiome J., 10. · DOI
  21. Penders, 2013, The human microbiome as a reservoir of antimicrobial resistance, Front. Microbiol., 4, 87, 10.3389/fmicb.2013.00087 · DOI · Paper page
  22. Spigaglia, 2016, Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection, Ther. Adv. Infect. Dis., 3, 23
  23. Tang, 2016, The incidence and drug resistance of Clostridium difficile infection in Mainland China: A systematic review and meta-analysis, Sci. Rep., 6, 37865, 10.1038/srep37865 · DOI
  24. Isidro, 2018, Genomic Study of a Clostridium difficile Multidrug Resistant Outbreak-Related Clone Reveals Novel Determinants of Resistance, Front. Microbiol., 9, 2994, 10.3389/fmicb.2018.02994 · DOI
  25. Kachrimanidou, M., and Tsintarakis, E. (2020). Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection. Microorganisms, 8. · DOI
  26. Gorrie, 2017, Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in Intensive Care Patients, Clin. Infect. Dis., 65, 208, 10.1093/cid/cix270 · DOI · Paper page
  27. Stercz, 2021, The influence of antibiotics on transitory resistome during gut colonization with CTX-M-15 and OXA-162 producing Klebsiella pneumoniae ST15, Sci. Rep., 11, 6335, 10.1038/s41598-021-85766-6 · DOI
  28. Patriarca, 2017, Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation, Biol. Blood Marrow Transplant., 23, 333, 10.1016/j.bbmt.2016.11.005 · DOI
  29. Macesic, 2018, Genomic Surveillance Reveals Diversity of Multidrug-Resistant Organism Colonization and Infection: A Prospective Cohort Study in Liver Transplant Recipients, Clin. Infect. Dis., 67, 905, 10.1093/cid/ciy199 · DOI
  30. 2015, The human gut resistome, Philos. Trans. R. Soc. Lond. B Biol. Sci., 370, 20140087, 10.1098/rstb.2014.0087 · DOI · Paper page
  31. Zhang, 2019, Facing a new challenge: The adverse effects of antibiotics on gut microbiota and host immunity, Chin. Med. J., 132, 1135, 10.1097/CM9.0000000000000245 · DOI
  32. Bui, 2019, Association between periodontal pathogens and systemic disease, Biomed. J., 42, 27, 10.1016/j.bj.2018.12.001 · DOI · Paper page
  33. Dutta, 2020, Bidirectional interaction between intestinal microbiome and cancer: Opportunities for therapeutic interventions, Biomark. Res., 8, 31, 10.1186/s40364-020-00211-6 · DOI
  34. Noor, 2019, The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials, J. Innate Immun., 11, 405, 10.1159/000492943 · DOI
  35. Vermeulen, 2019, Stem cells in homeostasis and cancer of the gut, Mol. Cancer, 18, 66, 10.1186/s12943-019-0962-x · DOI
  36. Kim, 2017, The interplay between host immune cells and gut microbiota in chronic inflammatory diseases, Exp. Mol. Med., 49, e339, 10.1038/emm.2017.24 · DOI · Paper page
  37. Kwon, 2016, Mechanism-based management for mucositis: Option for treating side effects without compromising the efficacy of cancer therapy, Onco Targets Ther., 9, 2007, 10.2147/OTT.S96899 · DOI
  38. Cassidy, 2020, Characterizing Chemotherapy-Induced Neutropenia and Monocytopenia through Mathematical Modelling, Bull. Math. Biol., 82, 104, 10.1007/s11538-020-00777-0 · DOI
  39. Shogbesan, 2018, A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients, Can. J. Gastroenterol. Hepatol., 2018, 1394379, 10.1155/2018/1394379 · DOI · Paper page
  40. Wendt, 2014, Clostridium difficile infection among children across diverse US geographic locations, Pediatrics, 133, 651, 10.1542/peds.2013-3049 · DOI
  41. Hourigan, 2014, The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease, Dig. Dis. Sci., 59, 2222, 10.1007/s10620-014-3169-4 · DOI
  42. Sunkersett, 2017, Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients, Biol. Blood Marrow Transplant., 23, 820, 10.1016/j.bbmt.2017.02.004 · DOI · Paper page
  43. Jouhten, 2016, Reduction of Antibiotic Resistance Genes in Intestinal Microbiota of Patients with Recurrent Clostridium difficile Infection after Fecal Microbiota Transplantation, Clin. Infect. Dis., 63, 710, 10.1093/cid/ciw390 · DOI · Paper page
  44. Millan, 2016, Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients with Recurrent Clostridium difficile Infection, Clin. Infect. Dis., 62, 1479, 10.1093/cid/ciw185 · DOI · Paper page
  45. Leung, 2018, Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection, Clin. Infect. Dis., 66, 456, 10.1093/cid/cix821 · DOI
  46. Schmid, H., Romanos, A., Schiffl, H., and Lederer, S.R. (2013). Persistent nasal methicillin-resistant staphylococcus aureus carriage in hemodialysis outpatients: A predictor of worse outcome. BMC Nephrol., 14. · DOI
  47. Prematunge, 2016, VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis, Infect. Control. Hosp. Epidemiol., 37, 26, 10.1017/ice.2015.228 · DOI · Paper page
  48. Huttner, 2013, Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: A randomized, double-blind, placebo-controlled trial, J. Antimicrob. Chemother., 68, 2375
  49. Lawley, 2013, Intestinal colonization resistance, Immunology, 138, 1, 10.1111/j.1365-2567.2012.03616.x · DOI · Paper page
  50. Caballero, 2017, Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium, Cell Host Microbe, 21, 592, 10.1016/j.chom.2017.04.002 · DOI · Paper page
  51. Becattini, 2017, Commensal microbes provide first line defense against Listeria monocytogenes infection, J. Exp. Med., 214, 1973, 10.1084/jem.20170495 · DOI · Paper page
  52. Kommineni, 2015, Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract, Nature, 526, 719, 10.1038/nature15524 · DOI · Paper page
  53. Mahieu, 2017, Impact of faecal microbiota transplantation on mouse digestive colonization with two extensively resistant bacteria, J. Infect., 75, 75, 10.1016/j.jinf.2017.04.008 · doi:10.1016/j.jinf.2017.04.008
  54. Gosalbes, 2016, Carriage of Enterobacteria Producing Extended-Spectrum β-Lactamases and Composition of the Gut Microbiota in an Amerindian Community, Antimicrob. Agents Chemother., 60, 507, 10.1128/AAC.01528-15 · DOI
  55. Pickard, 2019, Pathogen Colonization Resistance in the Gut and Its Manipulation for Improved Health, Am. J. Pathol., 189, 1300, 10.1016/j.ajpath.2019.03.003 · DOI
  56. Cascales, 2007, Colicin biology, Microbiol. Mol. Biol. Rev., 71, 158, 10.1128/MMBR.00036-06 · DOI · Paper page
  57. Mayer, 2019, Gut microbiota as a source of novel antimicrobials, Gut Microbes, 10, 1, 10.1080/19490976.2018.1455790 · DOI · Paper page
  58. Gillor, O., Giladi, I., and Riley, M.A. (2009). Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract. BMC Microbiol., 9. · DOI
  59. Umu, Ö.C., Bäuerl, C., Oostindjer, M., Pope, P.B., Hernández, P.E., Pérez-Martínez, G., and Diep, D.B. (2016). The Potential of Class II Bacteriocins to Modify Gut Microbiota to Improve Host Health. PLoS ONE, 11. · DOI
  60. Lamas, A., Regal, P., Vázquez, B., Cepeda, A., and Franco, C.M. (2019). Short Chain Fatty Acids Commonly Produced by Gut Microbiota Influence Salmonella enterica Motility, Biofilm Formation, and Gene Expression. Antibiotics, 8. · DOI
  61. Leatham, 2009, Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157:H7 growth in the streptomycin-treated mouse intestine, Infect. Immun., 77, 2876, 10.1128/IAI.00059-09 · DOI · Paper page
  62. Brown, J.R., Flemer, B., Joyce, S.A., Zulquernain, A., Sheehan, D., Shanahan, F., and O’Toole, P.W. (2018). Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection. BMC Gastroenterol., 18. · DOI
  63. Vincent, 2015, Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection, Antibiotics, 4, 230, 10.3390/antibiotics4030230 · DOI
  64. Staels, 2009, Bile acids and metabolic regulation: Mechanisms and clinical responses to bile acid sequestration, Diabetes Care, 32, S237, 10.2337/dc09-S355 · DOI · Paper page
  65. Ajouz, 2014, Secondary bile acids: An underrecognized cause of colon cancer, World J. Surg. Oncol., 12, 164, 10.1186/1477-7819-12-164 · DOI · Paper page
  66. 2018, Importance of microbial defence systems to bile salts and mechanisms of serum cholesterol reduction, Biotechnol. Adv., 36, 682, 10.1016/j.biotechadv.2017.12.005 · DOI
  67. Kochan, T.J., Shoshiev, M.S., Hastie, J.L., Somers, M.J., Plotnick, Y.M., Gutierrez-Munoz, D.F., Foss, E.D., Schubert, A.M., Smith, A.D., and Zimmerman, S.K. (2018). Germinant Synergy Facilitates Clostridium difficile Spore Germination under Physiological Conditions. mSphere, 3. · DOI
  68. Nie, 2015, Cross-talk between bile acids and intestinal microbiota in host metabolism and health, J. Zhejiang Univ. Sci. B, 16, 436, 10.1631/jzus.B1400327 · DOI
  69. Martin, 2018, In Vitro Modeling of Bile Acid Processing by the Human Fecal Microbiota, Front. Microbiol., 9, 1153, 10.3389/fmicb.2018.01153 · DOI
  70. Kong, 2018, Regulation of Intestinal Epithelial Cells Properties and Functions by Amino Acids, Biomed. Res. Int., 2018, 2819154, 10.1155/2018/2819154 · DOI · Paper page
  71. Huang, 2011, The human commensal Bacteroides fragilis binds intestinal mucin, Anaerobe, 17, 137, 10.1016/j.anaerobe.2011.05.017 · DOI · Paper page
  72. Kinoshita, 2007, Quantitative evaluation of adhesion of lactobacilli isolated from human intestinal tissues to human colonic mucin using surface plasmon resonance (BIACORE assay), J. Appl. Microbiol., 102, 116, 10.1111/j.1365-2672.2006.03061.x · DOI · Paper page
  73. Sicard, 2017, Interactions of Intestinal Bacteria with Components of the Intestinal Mucus, Front. Cell. Infect. Microbiol., 7, 387, 10.3389/fcimb.2017.00387 · DOI · Paper page
  74. Iacob, 2018, Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats, Front. Microbiol., 9, 3328, 10.3389/fmicb.2018.03328 · DOI · Paper page
  75. 2016, Bifidobacteria and Their Role as Members of the Human Gut Microbiota, Front. Microbiol., 7, 925
  76. Logan, 2018, The Vibrio cholerae type VI secretion system can modulate host intestinal mechanics to displace gut bacterial symbionts, Proc. Natl. Acad. Sci. USA, 115, E3779, 10.1073/pnas.1720133115 · DOI · Paper page
  77. Wu, 2020, Type III Secretion 1 Effector Gene Diversity Among Vibrio Isolates from Coastal Areas in China, Front. Cell. Infect. Microbiol., 10, 301, 10.3389/fcimb.2020.00301 · DOI
  78. Bierne, 2008, Listeria monocytogenes internalins bind to the human intestinal mucin MUC2, Arch. Microbiol., 190, 101, 10.1007/s00203-008-0358-6 · DOI
  79. Rehman, 2019, Adhesive mechanism of different Salmonella fimbrial adhesins, Microb. Pathog., 137, 103748, 10.1016/j.micpath.2019.103748 · DOI
  80. Ferreyra, 2014, Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance, Cell Host Microbe, 16, 770, 10.1016/j.chom.2014.11.003 · DOI · Paper page
  81. Coyne, 2005, Human symbionts use a host-like pathway for surface fucosylation, Science, 307, 1778, 10.1126/science.1106469 · DOI · Paper page
  82. Wands, 2015, Fucosylation and protein glycosylation create functional receptors for cholera toxin, eLife, 4, e09545, 10.7554/eLife.09545 · DOI · Paper page
  83. Dwivedi, 2016, L-fucose influences chemotaxis and biofilm formation in Campylobacter jejuni, Mol. Microbiol., 101, 575, 10.1111/mmi.13409 · DOI
  84. Sicard, 2018, N-Acetyl-glucosamine influences the biofilm formation of Escherichia coli, Gut Pathog., 10, 26, 10.1186/s13099-018-0252-y · DOI
  85. Schumann, 2012, Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model, Appl. Environ. Microbiol., 78, 1513, 10.1128/AEM.07340-11 · DOI
  86. Thiennimitr, 2011, Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota, Proc. Natl. Acad. Sci. USA, 108, 17480, 10.1073/pnas.1107857108 · DOI · Paper page
  87. Kamada, 2012, Regulated virulence controls the ability of a pathogen to compete with the gut microbiota, Science, 336, 1325, 10.1126/science.1222195 · DOI · Paper page
  88. Massip, 2020, Siderophore-Microcins in Escherichia coli: Determinants of Digestive Colonization, the First Step Toward Virulence, Front. Cell. Infect. Microbiol., 10, 381, 10.3389/fcimb.2020.00381 · DOI
  89. Lasaro, 2009, F1C fimbriae play an important role in biofilm formation and intestinal colonization by the Escherichia coli commensal strain Nissle 1917, Appl. Environ. Microbiol., 75, 246, 10.1128/AEM.01144-08 · DOI
  90. Nissle, 1961, Old and new experiences on therapeutic successes by restoration of the colonic flora with mutaflor in gastrointestinal diseases, Med. Welt, 29-30, 1519
  91. Kim, 2020, Recent insights into cellular crosstalk in respiratory and gastrointestinal mucosal immune systems, Immune Netw., 20, e44, 10.4110/in.2020.20.e44 · DOI
  92. Petersson, 2011, Importance and regulation of the colonic mucus barrier in a mouse model of colitis, Am. J. Physiol. Gastrointest. Liver Physiol., 300, G327, 10.1152/ajpgi.00422.2010 · DOI · Paper page
  93. Muzaki, 2017, Long-Lived Innate IL-17-Producing γ/δ T Cells Modulate Antimicrobial Epithelial Host Defense in the Colon, J. Immunol., 199, 3691, 10.4049/jimmunol.1701053 · DOI
  94. Cobo, 2013, Antimicrobial Human β-Defensins in the Colon and Their Role in Infectious and Non-Infectious Diseases, Pathogens, 2, 177, 10.3390/pathogens2010177 · DOI
  95. Dutta, 2016, Mammalian Antimicrobial Peptides: Promising Therapeutic Targets Against Infection and Chronic Inflammation, Curr. Top. Med. Chem., 16, 99, 10.2174/1568026615666150703121819 · DOI
  96. Fusco, 2017, Beta-Defensin-2 and Beta-Defensin-3 Reduce Intestinal Damage Caused by Salmonella typhimurium Modulating the Expression of Cytokines and Enhancing the Probiotic Activity of Enterococcus faecium, J. Immunol. Res., 2017, 6976935, 10.1155/2017/6976935 · DOI
  97. Diamond, 2009, The roles of antimicrobial peptides in innate host defense, Curr. Pharm. Des., 15, 2377, 10.2174/138161209788682325 · DOI · Paper page
  98. Ayabe, 2000, Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria, Nat. Immunol., 1, 113, 10.1038/77783 · DOI · Paper page
  99. Sugi, 2017, α-Defensin 5 gene expression is regulated by gut microbial metabolites, Biosci. Biotechnol. Biochem., 81, 242, 10.1080/09168451.2016.1246175 · DOI
  100. Menendez, 2013, Bacterial stimulation of the TLR-MyD88 pathway modulates the homeostatic expression of ileal Paneth cell α-defensins, J. Innate Immun., 5, 39, 10.1159/000341630 · DOI
  101. Miani, 2018, Gut Microbiota-Stimulated Innate Lymphoid Cells Support β-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes, Cell Metab., 28, 557, 10.1016/j.cmet.2018.06.012 · DOI · Paper page
  102. Yi, 2017, Cathelicidin-WA Improves Intestinal Epithelial Barrier Function and Enhances Host Defense against Enterohemorrhagic Escherichia coli O157:H7 Infection, J. Immunol., 198, 1696, 10.4049/jimmunol.1601221 · DOI
  103. Ju, T., Shoblak, Y., Gao, Y., Yang, K., Fouhse, J., Finlay, B.B., So, Y.W., Stothard, P., and Willing, B.P. (2017). Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli. Appl. Environ. Microbiol., 83. · DOI
  104. Thomas, M., Pierson, M., Uprety, T., Zhu, L., Ran, Z., Sreenivasan, C.C., Wang, D., Hause, B., Francis, D.H., and Li, F. (2018). Comparison of Porcine Airway and Intestinal Epithelial Cell Lines for the Susceptibility and Expression of Pattern Recognition Receptors upon Influenza Virus Infection. Viruses, 10. · DOI
  105. Vaishnava, 2011, The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine, Science, 334, 255, 10.1126/science.1209791 · DOI · Paper page
  106. Zheng, 2008, Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens, Nat. Med., 14, 282, 10.1038/nm1720 · DOI · Paper page
  107. Mukherjee, 2015, Antimicrobial defense of the intestine, Immunity, 42, 28, 10.1016/j.immuni.2014.12.028 · DOI · Paper page
  108. Dessein, 2009, Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis, Gut, 58, 771, 10.1136/gut.2008.168443 · DOI · Paper page
  109. Burger-van Paassen, N., Loonen, L.M., Witte-Bouma, J., Korteland-van Male, A.M., de Bruijn, A.C., van der Sluis, M., Lu, P., Van Goudoever, J.B., Wells, J.M., and Dekker, J. (2012). Mucin Muc2 deficiency and weaning influences the expression of the innate defense genes Reg3β, Reg3γ and angiogenin-4. PLoS ONE, 7. · DOI
  110. Valentini, 2014, Immunomodulation by gut microbiota: Role of Toll-like receptor expressed by T cells, J. Immunol. Res., 2014, 586939, 10.1155/2014/586939 · DOI
  111. Larsson, 2012, Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88, Gut, 61, 1124, 10.1136/gutjnl-2011-301104 · DOI · Paper page
  112. Tyler, 2017, Antigen-Presenting Human γδ T Cells Promote Intestinal CD4(+) T Cell Expression of IL-22 and Mucosal Release of Calprotectin, J. Immunol., 198, 3417, 10.4049/jimmunol.1700003 · DOI
  113. Xu, 2014, Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia, J. Immunol., 192, 1778, 10.4049/jimmunol.1300039 · DOI
  114. Ota, 2011, IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium, Nat. Immunol., 12, 941, 10.1038/ni.2089 · DOI · Paper page
  115. Sellau, 2016, IL-22 dampens the T cell response in experimental malaria, Sci. Rep., 6, 28058, 10.1038/srep28058 · DOI
  116. Behnsen, 2014, The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria, Immunity, 40, 262, 10.1016/j.immuni.2014.01.003 · DOI · Paper page
  117. Murray, 2017, Ligand activation of the Ah receptor contributes to gastrointestinal homeostasis, Curr. Opin. Toxicol., 2, 15, 10.1016/j.cotox.2017.01.003 · DOI
  118. Gao, 2018, Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism, Front. Cell. Infect. Microbiol., 8, 13, 10.3389/fcimb.2018.00013 · DOI · Paper page
  119. Yitbarek, 2018, Gut microbiota-mediated protection against influenza virus subtype H9N2 in chickens is associated with modulation of the innate responses, Sci. Rep., 8, 13189, 10.1038/s41598-018-31613-0 · DOI
  120. Chassaing, 2017, Tryptophan: A gut microbiota-derived metabolites regulating inflammation, World J. Gastrointest. Pharmacol. Ther., 8, 7, 10.4292/wjgpt.v8.i1.7 · DOI · Paper page
  121. Krishnan, 2018, Amphiregulin-producing γδ T cells are vital for safeguarding oral barrier immune homeostasis, Proc. Natl. Acad. Sci. USA, 115, 10738, 10.1073/pnas.1802320115 · DOI
  122. Duan, 2010, Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells, Cell Host Microbe, 7, 140, 10.1016/j.chom.2010.01.005 · DOI · Paper page
  123. Ueda, 2010, Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10, Int. Immunol., 22, 953, 10.1093/intimm/dxq449 · DOI
  124. Hayashi, 2013, A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice, Cell Host Microbe, 13, 711, 10.1016/j.chom.2013.05.013 · DOI · Paper page
  125. Morhardt, 2019, IL-10 produced by macrophages regulates epithelial integrity in the small intestine, Sci. Rep., 9, 1223, 10.1038/s41598-018-38125-x · DOI
  126. Ochi, 2016, Diet-dependent, microbiota-independent regulation of IL-10-producing lamina propria macrophages in the small intestine, Sci. Rep., 6, 27634, 10.1038/srep27634 · DOI
  127. Pallav, 2014, Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers: A randomized clinical trial, Gut Microbes, 5, 458, 10.4161/gmic.29558 · DOI
  128. Abeles, 2016, Microbial diversity in individuals and their household contacts following typical antibiotic courses, Microbiome, 4, 39, 10.1186/s40168-016-0187-9 · DOI · Paper page
  129. Engelbrektson, 2009, Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy, J. Med. Microbiol., 58, 663, 10.1099/jmm.0.47615-0 · DOI · Paper page
  130. Stewardson, 2015, Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: A culture-free analysis of gut microbiota, Clin. Microbiol. Infect., 21, 344.e341, 10.1016/j.cmi.2014.11.016 · DOI
  131. Vervoort, 2015, Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota, J. Antimicrob. Chemother., 70, 1989, 10.1093/jac/dkv062 · DOI
  132. Maukonen, 2008, Influence of oral doxycycline therapy on the diversity and antibiotic susceptibility of human intestinal bifidobacterial population, J. Appl. Microbiol., 105, 279, 10.1111/j.1365-2672.2008.03792.x · DOI
  133. Rashid, 2013, Ecological impact of doxycycline at low dose on normal oropharyngeal and intestinal microflora, Int. J. Antimicrob. Agents, 41, 352, 10.1016/j.ijantimicag.2012.11.014 · DOI

Cited by

See all 106

Metadata

Authors
Shah, T., Baloch, Z., Shah, Z., Cui, X., & Xia, X.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-06-20
Volume
22
Issue
12
Pages
6597
ISSN
1422-0067
Cited by
106
References
43
Language
en
Funders
  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China (U1702282)
  • the major science and technology special project of Yunnan Province (2019F004)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Intestinal Microbiota: Impacts of Antibiotics Therapy, Colonization Resistance, and Diseases. https://app.cochat.ai/papers/10.3390/ijms22126597
The paper
Shah, T., Baloch, Z., Shah, Z., Cui, X., & Xia, X. (2021). The Intestinal Microbiota: Impacts of Antibiotics Therapy, Colonization Resistance, and Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22126597

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.